Home Aldehydes 38544-16-0
38544-16-0,MFCD03422424
Catalog No.:AA00BZ1S

38544-16-0 | 2-(Benzyloxy)-5-chlorobenzaldehyde

Pack Size
Purity
Availability
Price(USD)
Quantity
  
1g
95%
in stock  
$37.00   $26.00
- +
5g
95%
in stock  
$95.00   $67.00
- +
25g
95%
in stock  
$263.00   $184.00
- +
  • Technical Information
  • Properties
  • Downstream Synthesis Route
  • Literature
  • Request for Quotation
  • Download SDS
  • Technical Information
  • Properties
  • Downstream Synthesis Route
  • Literature
Technical Information
Catalog Number:
AA00BZ1S
Chemical Name:
2-(Benzyloxy)-5-chlorobenzaldehyde
CAS Number:
38544-16-0
Molecular Formula:
C14H11ClO2
Molecular Weight:
246.6889
MDL Number:
MFCD03422424
SMILES:
O=Cc1cc(Cl)ccc1OCc1ccccc1
Properties
Computed Properties
 
Complexity:
238  
Covalently-Bonded Unit Count:
1  
Heavy Atom Count:
17  
Hydrogen Bond Acceptor Count:
2  
Rotatable Bond Count:
4  
XLogP3:
3.5  

Downstream Synthesis Route

[1]Lin,Chin-Fen;Yang,Jai-Sing;Chang,Chiung-Yun;Kuo,Sheng-Chu;Lee,Miau-Rong;Huang,Li-Jiau[BioorganicandMedicinalChemistry,2005,vol.13,#5,p.1537-1544]

[2]Ehrhart;Hennig[ChemischeBerichte,1954,vol.87,p.892,899]

[3]Shi,Wei-Kang;Deng,Rui-Cheng;Wang,Peng-Fei;Yue,Qin-Qin;Liu,Qi;Ding,Kun-Ling;Yang,Mei-Hui;Zhang,Hong-Yu;Gong,Si-Hua;Deng,Min;Liu,Wen-Run;Feng,Qiu-Ju;Xiao,Zhu-Ping;Zhu,Hai-Liang[BioorganicandMedicinalChemistry,2016,vol.24,#19,p.4519-4527]

[1]Aitken,R.Alan;Bouquet,Jaufret;Frank,Julia;Gidlow,AnnaL.G.;Powder,YomicaL.;Ramsewak,RusselS.;Reynolds,WilliamF.[RSCAdvances,2013,vol.3,#20,p.7230-7232]

[2]Nakazato,Atsuro;Ohta,Kohmei;Sekiguchi,Yoshinori;Okuyama,Shigeru;Chaki,Shigeyuki;Kawashima,Yutaka;Hatayama,Katsuo[JournalofMedicinalChemistry,1999,vol.42,#6,p.1076-1087]

[3]CurrentPatentAssignee:PFIZERINC-US2004/127465,2004,A1

[4]Locationinpatent:schemeortableGao,Guang;Gua,Feng-Lei;Jiang,Jian-Xiong;Jiang,Kezhi;Sheng,Chun-Qi;Lai,Guo-Qiao;Xu,Li-Wen[Chemistry-AEuropeanJournal,2011,vol.17,#9,p.2698-2703]

[1]Hall,Adrian;Atkinson,Stephen;Brown,SusanH.;Chessell,IainP.;Chowdhury,Anita;Giblin,GerardM.P.;Goldsmith,Paul;Healy,MarkP.;Jandu,KaramjitS.;Johnson,MatthewR.;Michel,AntonD.;Naylor,Alan;Sweeting,JenniferA.[BioorganicandMedicinalChemistryLetters,2007,vol.17,#5,p.1200-1205]

[2]CurrentPatentAssignee:GLAXOSMITHKLINEPLC-WO2005/54191,2005,A1Locationinpatent:Page/Pagecolumn26

[3]CurrentPatentAssignee:GLAXOSMITHKLINEPLC-WO2003/101959,2003,A1Locationinpatent:Page26

[4]CurrentPatentAssignee:ABBVIEINC-US2010/152160,2010,A1Locationinpatent:Page/Pagecolumn21

[5]Azevedo,CarlosM.G.;Afonso,CarlosM.M.;Sousa,Diana;Lima,RaquelT.;HelenaVasconcelos;Pedro,Madalena;Barbosa,João;Corrêa,ArleneG.;Reis,Salette;Pinto,MadalenaM.M.[BioorganicandMedicinalChemistry,2013,vol.21,#11,p.2941-2959]

[6]Hosten,EricC.;Hulushe,SiyaT.;Louzada,Marcel;Manyeruke,MeloddyH.;Rigin,Sergei;Watkins,GarethM.[RSCAdvances,2020,vol.10,#29,p.16861-16874]

[7]Chauhan,Divya;George,Ginson;Sridhar;Bhatia,Rohit;Paul,AtishT.;Monga,Vikramdeep[ArchivderPharmazie,2019,vol.352,#10]

[8]Kaye,PerryT.;Musa[SyntheticCommunications,2003,vol.33,#10,p.1755-1770]

[9]Nakazato,Atsuro;Ohta,Kohmei;Sekiguchi,Yoshinori;Okuyama,Shigeru;Chaki,Shigeyuki;Kawashima,Yutaka;Hatayama,Katsuo[JournalofMedicinalChemistry,1999,vol.42,#6,p.1076-1087]

[10]Kaye,PerryT.;Musa,MusiliyuA.[Synthesis,2002,#18,p.2701-2706]

[11]Chen,Han;Fan,Yun-Hua;Natarajan,Amarnath;Guo,Yuhong;Iyasere,Julia;Harbinski,Fred;Luus,Lia;Christ,William;Aktas,Huseyin;Halperin,JoseA.[BioorganicandMedicinalChemistryLetters,2004,vol.14,#21,p.5401-5405]

[12]Hall,Adrian;Atkinson,Stephen;Brown,SusanH.;Chessell,IainP.;Chowdhury,Anita;Clayton,NicholasM.;Coleman,Tanya;Giblin,GerardM.P.;Gleave,RobertJ.;Hammond,Beverley;Healy,MarkP.;Johnson,MatthewR.;Michel,AntonD.;Naylor,Alan;Novelli,Riccardo;Spalding,DavidJ.;Tang,SacP.[BioorganicandMedicinalChemistryLetters,2006,vol.16,#14,p.3657-3662]

[13]Matsuda,Takanori;Shigeno,Masanori;Murakami,Masahiro[JournaloftheAmericanChemicalSociety,2007,vol.129,#40,p.12086-12087]

[14]CurrentPatentAssignee:PFIZERINC-US2004/127465,2004,A1

[15]CurrentPatentAssignee:JOHNSON&JOHNSONINC-US2009/247618,2009,A1Locationinpatent:Page/Pagecolumn22

[16]CurrentPatentAssignee:JOHNSON&JOHNSONINC-WO2009/120192,2009,A2Locationinpatent:Page/Pagecolumn50

[17]Locationinpatent:schemeortableRashamuse,ThompoJ.;Musa,MusiliyuA.;Klein,Rosalyn;Kaye,PerryT.[JournalofChemicalResearch,2009,#5,p.302-305]

[18]Locationinpatent:schemeortableGao,Guang;Gua,Feng-Lei;Jiang,Jian-Xiong;Jiang,Kezhi;Sheng,Chun-Qi;Lai,Guo-Qiao;Xu,Li-Wen[Chemistry-AEuropeanJournal,2011,vol.17,#9,p.2698-2703]

[19]Aitken,R.Alan;Bouquet,Jaufret;Frank,Julia;Gidlow,AnnaL.G.;Powder,YomicaL.;Ramsewak,RusselS.;Reynolds,WilliamF.[RSCAdvances,2013,vol.3,#20,p.7230-7232]

[20]Olomola,TemitopeO.;Klein,Rosalyn;Kaye,PerryT.[Tetrahedron,2014,vol.70,#49,p.9449-9455]

[21]Manyeruke,MeloddyH.;Olomola,TemitopeO.;Majumder,Swarup;Abrahams,Shaakira;Isaacs,Michelle;Mautsa,Nicodemus;Mosebi,Salerwe;Mnkandhla,Dumisani;Hewer,Raymond;Hoppe,HeinrichC.;Klein,Rosalyn;Kaye,PerryT.[BioorganicandMedicinalChemistry,2015,vol.23,#24,p.7521-7528]

[22]Shen,Hongjuan;Fu,Junkai;Yuan,Hao;Gong,Jianxian;Yang,Zhen[JournalofOrganicChemistry,2016,vol.81,#21,p.10180-10192]

[1]Kaye,PerryT.;Musa[SyntheticCommunications,2003,vol.33,#10,p.1755-1770]

[2]Kaye,PerryT.;Musa,MusiliyuA.[Synthesis,2002,#18,p.2701-2706]

[3]Olomola,TemitopeO.;Klein,Rosalyn;Kaye,PerryT.[Tetrahedron,2014,vol.70,#49,p.9449-9455]

[4]Manyeruke,MeloddyH.;Olomola,TemitopeO.;Majumder,Swarup;Abrahams,Shaakira;Isaacs,Michelle;Mautsa,Nicodemus;Mosebi,Salerwe;Mnkandhla,Dumisani;Hewer,Raymond;Hoppe,HeinrichC.;Klein,Rosalyn;Kaye,PerryT.[BioorganicandMedicinalChemistry,2015,vol.23,#24,p.7521-7528]

[1]CurrentPatentAssignee:GLAXOSMITHKLINEPLC-WO2003/101959,2003,A1Locationinpatent:Page229

[2]Hall,Adrian;Atkinson,Stephen;Brown,SusanH.;Chessell,IainP.;Chowdhury,Anita;Clayton,NicholasM.;Coleman,Tanya;Giblin,GerardM.P.;Gleave,RobertJ.;Hammond,Beverley;Healy,MarkP.;Johnson,MatthewR.;Michel,AntonD.;Naylor,Alan;Novelli,Riccardo;Spalding,DavidJ.;Tang,SacP.[BioorganicandMedicinalChemistryLetters,2006,vol.16,#14,p.3657-3662]

Literature

Title: Synthesis and anticancer activity of benzyloxybenzaldehyde derivatives against HL-60 cells.

Journal: Bioorganic & medicinal chemistry 20050301

Quotation Request
Company Name:
*
Contact Person:
*
Email:
*
Quantity Required:
*
Country:
Additional Info:
SDS
Tags:38544-16-0 Molecular Formula|38544-16-0 MDL|38544-16-0 SMILES|38544-16-0 2-(Benzyloxy)-5-chlorobenzaldehyde